GSK (GSK,GSK.L,GS71.DE) reported first quarter pretax profit of 2.14 billion pounds compared to 2.11 billion pounds, prior year. Earnings per share was 42.6 pence compared to 39.3 pence. Core operating profit was 2.65 billion pounds, up 5% AER, and up 10% CER. Core EPS was 46.5 pence, up 4% AER, and up 9% CER. First quarter total sales were 7.6 billion pounds, up 2% AER, and up 5% CER.
GSK affirmed full-year 2026 guidance at constant exchange rates. The company expects 2026 turnover growth of between 3% to 5%; core operating profit growth of between 7% to 9%; and core EPS growth of between 7% to 9%.
At last close, GSK shares were trading at 2,027.50 pence, down 0.025%.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.